Using known risk factors for breast cancer, mathematical models can be advanced to help rejoinder foremost questions. These mathematical models are beneficial tools for researchers and for patients as follows:
1. Explore on risk factors - The Claus risk estimate model was used to study the subpopulation of population who had an autosomal dominant genetic allele that increased their risk from 10% to 92%. This led to the discovery of the Brca genes related with breast, ovarian, and prostate cancer.
2. Clinical trial eligibility - The Gail risk estimate model was advanced to help researchers determine who to enroll in the Nsapb Breast Cancer arresting Trials
where chemoprevention was shown to sell out breast cancer risk.
3. Guidelines for doing Brca testing - Brca testing is very high-priced and almost worthless if done on everyone (because it is so rare to be homozygous for Brca1 or Brca2). Mathematical models such as the Brcapro, Boadicea, and Tyrer-Cuzick models can help determine what patients should undergo Brca testing. The decision for testing is ordinarily made when one of these models predicts a 10% or greater occasion that there is a mutation of the Brca1, Brca2, or both genes.
4. Guidelines for doing Mri screening for breast cancer - Mri screening for breast cancer is not a cost effective screening test for the normal population, but in definite groups, there are clear cut reasons to do so. In general, screening Mri is recommended for women with 20-25% or greater lifetime risk of breast cancer. The Brcapro and Tyrer-Cuzick models have been used to help make clinical decisions about ordering Mris for breast cancer screening.
5. Guidelines for breast cancer therapy - The Gail model is used clinically to help
determine who should be put on tamoxifen or raloxifene for chemoprevention. Other models have been used to help make decisions about breast cancer risk allowance with inhibitive mastectomy.
For these reasons, it is foremost to understand these models. These models are collectively referred to as "risk estimate tools". The following paragraphs summarize the most favorite and most widely used risk estimate tools. Keep in mind that none of these risk estimate tools apply to breast cancer survivors. No mathematical model has been widely standard to determine cancer risk in cancer survivors.
General Risk estimate Tools
Gail Model: The Gail model is a validated risk-assessment model that focuses primarily on nonhereditary risk factors, with little information on house history. It was advanced by scientists at the National Cancer institute and the National Surgical Adjuvant Breast and Bowel scheme (Nsabp) to sustain condition care providers in discussing breast cancer risk to determine their eligibility for the Breast Cancer arresting Trial. The tool allows one to scheme a woman's individual estimate of breast cancer risk over a five-year duration of time and over her lifetime. It also compares the woman's risk calculation with the median risk for a woman of the same age. The Gail Model is an on-line quiz that has 13 questions and is interactive. This calculator is based on published risk statistics and methods gathered from peer-reviewed journals, and has been extensively tested for its validity.
The major limitation of the Gail model is the inclusion of only first-degree relatives, which results in underestimating risk in the 50% of families with cancer in the paternal lineage and also takes no inventory of the age of onset of breast cancer. It may underestimate risk in distinct groups, such as obese patients.
National Cancer institute Model: The Nci risk estimate tool is essentially a simplified Gail Model that also factors in race. Race is a factor in determining breast cancer risk but is excluded when determining eligibility for clinical trials. This tool is probably the most favorite risk estimate tool ready to the group as an on-line, interactive risk calculator. The on-line quiz is a shorter, nine-point questionnaire that includes multiple factors, giving a woman her time to come five-year risk of breast cancer and her lifetime risk of breast cancer.
The Nci tool does not inventory for a lot of risk factors that can be modified. For this reason, it is difficult to use this test as a motivation tool to show population how lifestyle can alter their risk of breast cancer. It also cannot be used in breast cancer survivors, in patients with Dcis, Lcis, or population who carry one of the Brca genes.
Brcapro model: This is a statistical model ready as a computer agenda that uses two dissimilar algorithms to rate house history and helps a doctor determine the likelihood of finding either a Brca1 mutation or a Brca2 mutation in a family. The results of this can be used to determine if Brca testing is indicated. This is very beneficial in light of the high cost of Brca testing (,000). None of the nonhereditary risk factors can yet be incorporated into the model, however. In a comparison of four dissimilar methods for estimating breast cancer risk in patients with a house history of breast cancer, the Brcapro model was the least accurate. It imaginable only 49% of the breast cancers that in fact occurred in the screened group of patients with a house history of breast cancer.
Harvard center for Cancer arresting Risk estimate Tool: This is someone else breast cancer risk estimate tool that includes more lifestyle factors than the Nci or Gail Model tools. It has not been studied as extensively as the Gail Model or the simplified Nci model, but it is promising in that it includes many lifestyle factors that population can do to modify their risk of developing cancer. It is also an on-line questionnaire that can be used by both women and men to estimate their breast cancer risk.
Making all this practical
Now after a standard and confusing seminar of all these statistical models, it's time to make all this information practical. What is the best way to help a patient accurately collate her risk of breast cancer and if possible, show her what distinct factors are reducing her risk and what negative factors can be changed to sell out her risk? If possible, it would also be great to show the patient the value and indications for testing, imaging, chemoprevention, and in some cases surgery. A seminar of the practical aspect of each of these is addressed in a Q & A format below:
Q: What (free) online programs can be used to help a patient collate their risk of breast cancer?
A: several of the risk estimate tools mentioned above can be accessed for free by the public. Here are the tests and their websites:
1. Your Disease Risk - English version: www.diseaseriskindex.harvard.edu
This is a great interactive questionnaire that calculates five-year and lifetime risk of breast cancer advanced by the Harvard center for Cancer arresting and made group online in 2000. In 2005, they launched the Spanish version of the site, "Cuidar de su Salud". The risk calculator includes lifestyle factors such as weight, dietary vegetables, alcohol intake, as well as Jewish ethnicity. It does not contain other ethnicities, however, and is not definite for Brca mutation carriers or breast cancer survivors. Despite these issues, this is by far the best free online risk calculator since it is very interactive and gives you a personalized article of your risk in the form of a colored bar graph, which they can electronically manipulate to perceive "virtual" risk reduction. The bar graph is a seven-level scale that compares users to a typical man or woman your age. Users learn where to focus their arresting efforts and how to make lifestyle changes by "clicking on" personalized strategies. With each click, the bar graph shrinks, and the user watches his/her imaginable risk drop. This is a great belief to motivate population to partake and comply with lifestyle modification measures.
2. The Nci Risk estimate Tool -regular web: www.cancer.gov/bcrisktool
This is the easy to use, on-line questionnaire based on a modified Gail model that also includes ethnicity. It does not factor in a personal history of breast cancer, Dcis, or Lcis. It does not inventory for other factors such as Brca status, hormonal exchange therapy, lifestyle factors, breast feeding, menopause, or mammographic density. Despite these issues, it is a very beneficial tool that gives a woman her five-year and lifetime risk of breast cancer. It is the only risk estimate tool that can be used via mobile handheld devices (any type). A version of this can be downloaded for Pdas with Windows Pocket Pc operating law as well.
Q: What programs can be used to help a doctor make decisions about ordering a breast Mri?
A: The American Cancer community has advanced some very good guidelines for breast cancer screening with Mri. It should be emphasized that Mri is an adjunct to mammography, not a replacement. Some programs can be used to help in clinical decision making. Please look up the American Cancer community website.
Surgery Journal:How to infer Your Risk For Breast Cancer
ไม่มีความคิดเห็น:
แสดงความคิดเห็น